Screener
Solid Biosciences Inc. SLDB Change In Fair Value Of Derivative Liabilities
Change In Fair Value Of Derivative Liabilities at other companies
Other financials
Where this comes from
Reported directly by Solid Biosciences Inc. in its filing.
Tagged under the XBRL concept sldb:ChangeInFairValueOfDerivativeLiabilities.
The source filing: Solid Biosciences Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:04 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337935
FAQ
- What is Solid Biosciences Inc.'s change in fair value of derivative liabilities?
- Solid Biosciences Inc. (SLDB) reported change in fair value of derivative liabilities of -$850K in Q2 2026.
- How has Solid Biosciences Inc.'s change in fair value of derivative liabilities changed year-over-year?
- Solid Biosciences Inc.'s change in fair value of derivative liabilities increased by 5.6% year-over-year, from -$900K to -$850K.
- What does change in fair value of derivative liabilities mean?
- This represents the non-cash gain or loss resulting from the periodic revaluation of derivative instruments, such as warrants or embedded options. Fluctuations in this metric reflect changes in market sentiment or the company's stock price volatility. It is essential for understanding non-operating volatility in the company's financial results.
Ask your AI about Solid Biosciences Inc.'s change in fair value of derivative liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude